Call Us + 33 1 84 88 31 00

Article R5124-62 of the French Public Health Code

The depositories defined in 4° of article R. 5124-2 carry out their activities under the conditions set out in a written contract which, in accordance with the good practices provided for in article L. 5121-5, applicable to these activities, sets out the respective obligations of the depository and the operator, manufacturer or importer on whose behalf it is acting. They may only distribute batches of medicinal products or other pharmaceutical…

Read More »

Article R5124-63 of the French Public Health Code

The approval of a not-for-profit humanitarian organisation as provided for in article L. 5124-7 is granted by the Minister for Health, after obtaining the opinion of the Minister for Humanitarian Action and, depending on the location of the proposed pharmaceutical establishment, of the Central Council of Section C or E of the National Order of Pharmacists. If the Minister remains silent on the application for approval for more than four…

Read More »

Article R5124-63-1 of the French Public Health Code

Humanitarian wholesale distributors as defined in 8° of article R. 5124-2 are subject to compliance with good practice in the donation of medicinal products, set by order of the Minister for Health and relating in particular to the quality, shelf life and storage of products.

Read More »

Article R5124-64 of the French Public Health Code

Wholesalers of medicinal plants shall, with regard to the operations they carry out and prior to marketing, check the identification of the plants and release the batches defined during the operations carried out. They shall also ensure that the plants are properly preserved during the operations carried out and until they are delivered. Any operations carried out on these plants must not modify their botanical or organoleptic properties or affect…

Read More »

Article R5124-65 of the French Public Health Code

Subject to the provisions of article L. 1453-7, and articles L. 4311-28, L. 4321-20 and L. 4343-1, advertising in favour of pharmaceutical companies and establishments may not include any offer of premiums, objects, products or material advantages, provided directly or indirectly, of any nature whatsoever, unless they are of negligible value.

Read More »

Article R5124-66 of the French Public Health Code

Pharmaceutical establishments and companies are authorised to make donations to legal entities for the purpose of encouraging research or the training of health professionals, subject to prior declaration to the Director General of the Regional Health Agency of the place where the registered office of the beneficiary organisation is located and on condition that the real purpose of these donations is not to provide an individual advantage to a member…

Read More »

Article R5124-67 of the French Public Health Code

Where advertising in favour of a pharmaceutical company or establishment mentions a medicinal product, it is governed by the provisions of sections 1, 2 and 3 of Chapter II of this Title; where it mentions a product or object listed in section 4 of the same chapter, it is governed by the provisions of that section. The provisions of the previous paragraph do not apply to scientific, technical or financial…

Read More »

Article R5124-68 of the French Public Health Code

In order to carry out the activities listed in the first paragraph of article L. 5124-1, within the limits defined by the present section, public health establishments which meet the condition set out in article L. 5124-9, create one or more pharmaceutical establishments within their walls, by decision of their board of directors. They must obtain the authorisation referred to in article L. 5124-3 for these establishments. Subject to the…

Read More »

Article R5124-69 of the French Public Health Code

The activities of pharmaceutical establishments managed by public health establishments may only concern medicinal products that meet public health needs that are not already satisfied by medicinal products available in France and benefiting from the marketing authorisation provided for in article L. 5121-8 or the early access authorisation or compassionate access authorisation referred to in article L. 5121-12 and II of article L. 5121-12-1. The content of the annual report…

Read More »

Article R5124-70 of the French Public Health Code

In support of the application for authorisation provided for in article L. 5124-3, public health establishments must prove that they were manufacturing medicinal products industrially on 31 December 1991 and specify the nature and quantities of medicinal products manufactured annually.

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.